6DECEMBER - 2022TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comAs innovation and precision medicine transforms the healthcare landscape, science, and data are becoming the foundation for pharma to meet its obligations to patients and customers, and realize commercial opportunities. This imperative is accelerating the evolution of medical affairs as the third strategic pillar of the organization alongside R&D and commercial.Medical affairs leaders are seeking new data sources, competencies, and technology solutions to bring greater transparency and collaboration to scientific communications. Advanced analytics of patient data have become central, for example, to support decision making on product use and to demonstrate patient value in a real-life setting--driven by the appetite of both external and internal stakeholders for meaningful interpretation of patient data.Experts predict that the medical affairs market is expected to reach $4.28 billion by 2030, with a CAGR of 12.2 percent. To put the spotlight on such key developments in the industry, Pharma Tech Outlook illustrates how the medical affairs space is leveraging high readiness to innovation with utilizing modern technologies This edition also features thought leadership articles from subject matter experts. Some of the exclusive insights are authored by Itedale Namro Redwan, CSO at CELLINK, Jon Kallay, Senior Technology and Market Development Manager at Charles River Laboratories, and Alexander Bernikov, Medical Director, Clinical Development (Uro)-Oncology, Jiangsu Hengrui Pharmaceuticals. They shed light on the field of 3D bioprinting, cell and gene therapy manufacturing processes, and the use of AI and ML providing novel services and solutions for different industries. In this edition of Pharma Tech Outlook, we also bring to you the story of the top medical affairs solution providers leveraging the importance of communication. In the list, The Medical Affairs Company stands out for seeking to empower through knowledge, advance healthcare, and enrich patients' lives. It offers a comprehensive portfolio that promises to deliver the right message to the right people in the right way. Through the following pages, we aim to shine a light on the innovative trends and latest developments in the medical affairs industry. We would like to know your thoughts.Precision Medicine Set to Improve the Medical Affairs IndustryCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 20 - 2022, Vol 08 - Issue 20 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizerRonald DonovanEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul Barbersales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Parley MeadowTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >